Correlation Between Bright Minds and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bright Minds and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bright Minds and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bright Minds Biosciences and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Bright Minds and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bright Minds with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bright Minds and Lipella Pharmaceuticals.
Diversification Opportunities for Bright Minds and Lipella Pharmaceuticals
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bright and Lipella is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Bright Minds Biosciences and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Bright Minds is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bright Minds Biosciences are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Bright Minds i.e., Bright Minds and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bright Minds and Lipella Pharmaceuticals
Given the investment horizon of 90 days Bright Minds Biosciences is expected to generate 0.8 times more return on investment than Lipella Pharmaceuticals. However, Bright Minds Biosciences is 1.24 times less risky than Lipella Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about -0.08 per unit of risk. If you would invest 3,859 in Bright Minds Biosciences on September 25, 2024 and sell it today you would earn a total of 6.00 from holding Bright Minds Biosciences or generate 0.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bright Minds Biosciences vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Bright Minds Biosciences |
| Lipella Pharmaceuticals |
Bright Minds and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bright Minds and Lipella Pharmaceuticals
The main advantage of trading using opposite Bright Minds and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bright Minds position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Bright Minds vs. Fate Therapeutics | Bright Minds vs. Caribou Biosciences | Bright Minds vs. Arcus Biosciences | Bright Minds vs. Karyopharm Therapeutics |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |